NowPatient review
Graded on whether a price is published, checkable, and still true at month two — how we grade · how we verify prices
NowPatient sells Mounjaro to American buyers from $251.98. The pharmacy, the regulator and the courts are all British, and no page states how long that price lasts.
Neither figure is a monthly price. No product page states a billing cycle at all, and $75 of shipping and customs duties is added unless you buy the membership.
- Advertised $99, actually $251.98
- No month-to-month price published
- States not published
- FDA warning letters: 0 of 0 matched
- Prices read September 2026
Read first-hand, not from a feed.
Distinct plans priced.
Added by the time you're billed.
This link pays us nothing. It's here because the price is checkable.
The verdict
It is a real prescribing and dispensing pharmacy, not a savings card — but it is a British one selling into the United States with no US prescriber named, no billing cycle stated anywhere, and two plainly wrong statements about the drugs on its own medically reviewed pages.
This link pays us nothing. It's here because the price is checkable.
Quick facts
Key facts
- Mounjaro
- From $251.98 per order
- Wegovy injection
- From $215.98 per order
- Wegovy tablets
- From $99.00 per order
- Billing cycle
- Not stated on any product page
- Shipping and duties
- $75 on top unless you buy the membership
- Legal entity
- Infohealth Limited, registered in England and Wales
- Regulator
- The General Pharmaceutical Council, in Britain
- Jurisdiction
- England and Wales, exclusively — no US forum
- US prescriber
- None named across twenty-one pages
- Clinical accuracy
- Two wrong drug statements on a medically reviewed page
Pros and cons
What we like
- It is a genuine prescribing and dispensing pharmacy rather than a discount or savings scheme.
- Prices are printed openly on individual product pages, with no signup needed to see them.
- The legal entity is named with its company registration number and registered address.
- The pharmacy is named and its regulator and registration number are published.
- It states that its prices include customs duties, rather than surprising buyers at delivery.
- Wegovy tablets at $99 are among the cheaper branded options we have seen published anywhere.
What could be better
- No billing cycle is stated against any price, so no monthly cost can be worked out.
- The entity, pharmacy, regulator and exclusive jurisdiction are all British, leaving a US buyer no US forum.
- No US prescribing group or US-licensed prescriber is named anywhere.
- A "Free Next-Day Delivery" headline sits beside dollar prices while its own footnote limits it to the UK.
- The Mounjaro page directs readers to NHS 111 and to call 999 in an emergency.
- Semaglutide is described as the active ingredient of Mounjaro and Zepbound, which is wrong.
- Saxenda is described as once-weekly, which is wrong.
- The terms never mention membership, subscription or renewal despite advertising a recurring charge.
- The same drugs are priced in sterling on two other pages of the US site.
What it is
NowPatient sells branded GLP-1 medication — Mounjaro, Wegovy, Wegovy tablets and others — to buyers including Americans. It genuinely prescribes and dispenses rather than brokering discounts, which puts it in a different category from a savings card, though not in the same one as a US telehealth prescriber.
The entity is Infohealth Limited, registered in England and Wales under company number 04004930, with a pharmacy arm regulated by the General Pharmaceutical Council. Its terms give the courts of England and Wales exclusive jurisdiction. An American buyer therefore has no US forum, and no US state board stands behind the prescription.
Across twenty-one pages we found no US prescribing group, no US state board and no requirement that a US-licensed prescriber be involved — while a page marketed to Americans advertises "board-certified clinicians". The company's own statement is that its prescribing services are regulated by the GPhC, which is the British regulator.
Every price we found
| Plan | Advertised | What you actually pay | The gap | Read on |
|---|---|---|---|---|
| MounjaroPer order. No billing cycle is stated. Shipping and duties add $75.00 unless you hold the membership. | not published | $251.98 | not comparable | September 2026 |
| Wegovy injectionPer order, with no stated billing cycle. | not published | $215.98 | not comparable | September 2026 |
| Wegovy tabletsPer order, with no stated billing cycle. The cheapest branded option on the site. | not published | $99.00 | not comparable | September 2026 |
| FoundayoPer order, with no stated billing cycle. | not published | $113.85 | not comparable | September 2026 |
This link pays us nothing. It's here because the price is checkable.
What it actually costs
Mounjaro from $251.98, Wegovy from $215.98, Wegovy tablets from $99. These are per-order prices — no page states a billing cycle for any of them.
That is the problem with comparing NowPatient to anything. Every other seller on this roster prices a month, a quarter or a year; this one prices an order, and never says what an order lasts. There is no "monthly", no "per month", no "subscription" against any price on any product page. So we publish these as per-order figures and decline to convert them, because converting them would mean inventing the seller's billing model on its behalf.
Shipping and customs duties add $75 unless you pay for the membership, and the site says its prices include customs duties wherever you are located. The membership itself is advertised at a monthly rate on the homepage — but its only source is an accordion on the bare homepage with no pricing page anywhere on the site, so we do not publish that figure as a price. The terms are silent on it in a more troubling way: they contain no mention of membership, subscription or renewal at all, despite a recurring charge being advertised.
A heading promises "Free Next-Day Delivery†" beside dollar prices. The dagger reads: applies to UK only.
The same mismatch runs through the clinical content. The Mounjaro page tells its reader to contact NHS 111 and to call 999 in an emergency. Returns go to Surrey, England, under a European cooling-off right with no US equivalent. And the prices themselves are not stable across the US locale: the same drugs appear at a sterling price on two other pages of the American site.
Two statements on its medically reviewed weight-loss hub are simply wrong: semaglutide is described as the active ingredient of Mounjaro and Zepbound, which it is not, and Saxenda is described as once-weekly, which it is not either. Those are not pricing errors, and they are the reason this grades where it does — a page that cannot state which molecule is in which brand is not a safe place to learn what you are taking.
Who it's wrong for
- Almost any American buyer who expects US recourse. The entity, the pharmacy and the exclusive jurisdiction are all British.
- Anyone who needs to budget. No page states a billing cycle, so there is no monthly cost to calculate.
- Anyone who reads the delivery promise. "Free Next-Day Delivery" applies to the UK only, and US orders carry $75 of shipping and duties.
- Anyone learning about their medication here. Two statements about which drug contains what are wrong on a medically reviewed page.
- Anyone buying the membership. It is advertised as recurring and the terms never mention membership, subscription or renewal.
Medications available
- MounjaroBrandFrom $251.98 per order
- Wegovy injectionBrandFrom $215.98 per order
- Wegovy tabletsBrandFrom $99.00 per order
The cheapest branded option published here.
- FoundayoBrandFrom $113.85 per order
Is NowPatient legit?
NowPatient is operated by Infohealth Limited, registered in England and Wales, company number 04004930, Lynwood House, 373–375 Station Road, Harrow, England, HA1 2AW. We read that off the company’s own terms of use on September 2026.
What that means
A known-positive control passed in the same run, so a real match would have surfaced. A letter would be worth knowing about; it would not by itself disqualify a seller.Pharmacy, prescribers and safety checks
- Legal entityInfohealth Limited, England and Wales, number 04004930
- PharmacyInfohealth Pharmacy, GPhC registered
- RegulatorThe General Pharmaceutical Council — British, not US
- US prescriberNone named across twenty-one pages
- JurisdictionEngland and Wales, exclusive
- Drug formBrand, not compounded
- Billing cycleNot stated anywhere
- Shipping and duties$75.00 added unless you hold the membership
- Clinical accuracyTwo incorrect drug statements on a medically reviewed page
- States servedNot applicable — it ships worldwide rather than by state
Common questions
How much does NowPatient cost per month?
There is no monthly price. Mounjaro starts at $251.98, Wegovy at $215.98, Wegovy tablets at $99.00 and Foundayo at $113.85 — but no product page states a billing cycle, so these are per-order prices and a monthly cost cannot be worked out from what the site publishes.
Is NowPatient a US pharmacy?
No. The entity is Infohealth Limited, registered in England and Wales under company number 04004930, and its pharmacy arm is regulated by the General Pharmaceutical Council, the British regulator. Its terms give the courts of England and Wales exclusive jurisdiction, so a US buyer has no US forum.
Who prescribes for NowPatient in the United States?
No US prescribing group, US state board or US-licensed prescriber is named anywhere across the twenty-one pages we read. The company says its prescribing services are regulated by the GPhC, while a page aimed at American readers advertises board-certified clinicians.
Does NowPatient offer free delivery?
Not to the United States. A heading promises "Free Next-Day Delivery" beside prices in dollars, and the footnote attached to it reads that it applies to the UK only. US orders carry $75.00 in shipping and customs duties unless you hold the membership.
Are NowPatient's prices in US dollars?
On the product pages, yes — we confirmed the dollar and sterling versions render differently for the US and UK locales. But the same drugs appear at sterling prices on two other pages of the US site, so the currency is not consistent across the site a US buyer sees.
Is NowPatient's medical information reliable?
We found two clear errors on its medically reviewed weight-loss hub: semaglutide is described as the active ingredient of Mounjaro and Zepbound, which it is not, and Saxenda is described as once-weekly, which it is not. Those are basic facts about which molecule is in which brand.
Why we gave NowPatient a F
Read the full grading rationale
NowPatient does sell real branded GLP-1s to American buyers at published prices on real pages — Mounjaro from $251.98, Wegovy from $215.98, Wegovy tablets from $99 — and it is a genuine prescribing and dispensing operation rather than a savings card. Everything about who is responsible for that prescription is British. The entity is Infohealth Limited, registered in England and Wales under company number 04004930; the pharmacy is Infohealth Pharmacy, regulated by the General Pharmaceutical Council; and the terms give England and Wales exclusive jurisdiction, so an American buyer has no US forum. No US state board, no US prescribing group and no US-licensed-prescriber requirement appears anywhere across 21 pages, though a page advertising to Americans promises "board-certified clinicians". No page states a billing cycle for any price, so these are per-order figures and nobody can work out what a month costs. Shipping and customs duties add $75, and the site says its prices include customs duties wherever you are. A heading promises "Free Next-Day Delivery†" beside dollar prices, and the dagger reads "Applies to UK only". The Mounjaro page tells its reader to contact NHS 111 and to call 999 in an emergency. Two statements on its medically reviewed weight-loss hub are simply wrong: semaglutide is described as the active ingredient of Mounjaro and Zepbound, and Saxenda as once-weekly. The terms contain no mention of membership, subscription or renewal, despite a $9.99 monthly charge the homepage advertises.
What that means
Screening is by entity — the company’s own domain plus the address it publishes — never by brand name, because a brand name matches every namesake. Where a company publishes no address, the address half of that match is never exercised, and the result is recorded as the weaker kind of absence rather than a clean record. A known-positive control passed in the same run, so a real match would have surfaced. A letter would be worth knowing about; it would not by itself disqualify a seller.How we reviewed NowPatient
- We read twenty-one pages in full, spaced two to four seconds apart, and no request was throttled or refused, so the absences we report are measured rather than blocked.
- We proved the currency rather than assuming it, by loading the same product page in the US and UK locales and comparing the rendered price and shipping lines.
- We searched every product page for the words that would establish a billing cycle — monthly, per month, recurring, subscription — before recording that none is stated. That absence is the single most important fact about these prices.
- The membership fee is real and we have deliberately not published its figure: the only place it appears is an accordion on the bare homepage, there is no pricing, plans or membership path anywhere on the site, and the footer's own FAQ link resolves to the homepage. A price with no source but a domain root is not publishable here.
- We walked both public entry points. One opens a third-party lead form that defaults its phone field to a United Kingdom country code even on the US page; the other is a four-screen eligibility quiz that never asks for a state, a ZIP or a country and ends on a booking prompt with no price. Neither was submitted.
- A nonsense-path control on the host returned a 404 at 114,128 bytes against a 200 at 893,768 for a real product page, so this host discriminates.
- The FDA warning-letter screen ran on the company's own domain and published address, with a known-positive and a known-negative control passing in the same run. It returned no candidate letters, and we note that a British registered address is not something an FDA warning-letter corpus would be expected to carry in a matchable form.
The 4 pages we read — all on
- Mounjaro page
Mounjaro From $251.98 Shipment & duties $75.00
- Wegovy page
Wegovy From $215.98
- Wegovy tablets page
Wegovy tablets From $99.00
- Foundayo page
Foundayo From $113.85
This link pays us nothing. It's here because the price is checkable.
Alternatives to NowPatient
| Provider | Grade | Cheapest price |
|---|---|---|
| Alternate Health Club | CCaveat | $99/mo |
| Boston Medical Group | FFail | $99/mo |
| Cora Health | BMinor gap | $99/mo |
| Eden | CCaveat | $99/mo |
| Embody | FFail | $99/mo |